title: Miller Fisher syndrome possibly related to mycoplasma pneumoniae infection: report of one case.
abstract: Ophthalmoplegia, ataxia, and areflexia were first described in 1956 by Miller Fisher and later were referred to as symptoms of Miller Fisher syndrome (MFS). This syndrome shares certain features with the Guillain-Barré syndrome (GBS), including areflexia, cerebrospinal fluid findings and often a postinfectious presentation. It was believed to be a variant of GBS, but Miller Fisher syndrome has several key clinical features which differ from GBS. The anatomic location and pathogenesis of MFS continue to be a matter of debate. Our report focuses on a 6-year-old female patient who developed MFS following a respiratory tract infection with a serologically proven Mycoplasma pneumoniae infection. Although several neurological complications after Mycoplasma pneumoniae infection have been reported, subsequent MFS development has rarely been reported previously.
authors.affiliation: Department of Pediatrics, China Medical University Hospital, Taichung, Taiwan.
authors.forename: Kai-Chung
authors.initials: KC
authors.lastname: Hsueh
authors.forename: I-Ching
authors.initials: IC
authors.lastname: Chou
authors.forename: Ching-Hsiang
authors.initials: CH
authors.lastname: Hsu
authors.forename: Huang-Tsung
authors.initials: HT
authors.lastname: Kuo
authors.forename: Fuu-Jen
authors.initials: FJ
authors.lastname: Tsai
authors.forename: Chang-Hai
authors.initials: CH
authors.lastname: Tsai
mesh_terms: D000907:Antibodies, Bacterial / Q000097:blood; D002648:Child; D005260:Female; D005334:Fever / Q000209:etiology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D019846:Miller Fisher Syndrome / Q000188:drug therapy / Q000209:etiology*; D009177:Mycoplasma pneumoniae / Q000187:drug effects / Q000276:immunology; D011019:Pneumonia, Mycoplasma / Q000150:complications* / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000907:Antibodies, Bacterial; D016756:Immunoglobulins, Intravenous